| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 74791 |
ALD-tetra-EG-Osu的介绍 |
120 |
zyl |
2024-12-19 |
| 74792 |
SSTR2靶向肽Tyr(3)-奥曲肽(tate) |
217 |
h |
2024-12-19 |
| 74793 |
DOTA-D-Phe(1)-Tyr(3)-Octreotide |
90 |
h |
2024-12-19 |
| 74794 |
cas:55750-63-5，Mal-heptanoic NHS ester |
109 |
zyl |
2024-12-19 |
| 74795 |
DOTA-Fab-PEG24-EGF DOTA-PEG修饰曲妥珠单抗Fab片段偶联表皮生长因子 |
97 |
h |
2024-12-19 |
| 74796 |
cas:663599-10-8，DMAC-SPP |
103 |
zyl |
2024-12-19 |
| 74797 |
多甲基化的1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸(DOTA)配体 |
142 |
h |
2024-12-19 |
| 74798 |
PEG-pGlu(DOTA)8-LA4 |
54 |
h |
2024-12-19 |
| 74799 |
cas:937025-17-7，2,5-Dioxopyrrolidin-1-yl 2-oxo-6,9,12,15-tetraoxa-3-thiaoctadecan-18-oate |
141 |
zyl |
2024-12-19 |
| 74800 |
DOTA-Hyd-TRP PET示踪剂 |
102 |
h |
2024-12-19 |
| 74801 |
Ga-DOTATOC Ga-DOTA-D-Phe-Tyr-奥曲肽 |
144 |
h |
2024-12-19 |
| 74802 |
cas:1226371-65-8，N-(2-(2,5-Dimethylphenoxy)ethyl)-4-formylbenzamide |
79 |
zyl |
2024-12-19 |
| 74803 |
DOTA-ALN DOTA-阿仑膦酸盐 |
84 |
h |
2024-12-19 |
| 74804 |
氨氯地平DOTA偶联物 DOTA-Amlodipine |
145 |
h |
2024-12-19 |
| 74805 |
cas:906564-59-8，Propargyl-C2-NHS ester |
98 |
zyl |
2024-12-19 |
| 74806 |
DOTA-Gp2-EGFR DOTA螯合剂标记结合表皮生长因子受体EGFR靶向Gp2 |
87 |
h |
2024-12-19 |
| 74807 |
cas:894095-98-8，β-D-glucuronide-pNP-carbonate |
77 |
zyl |
2024-12-19 |
| 74808 |
DOTA结合肽功能化金纳米粒子 |
91 |
h |
2024-12-19 |
| 74809 |
90Y-DOTA-Bn 钇-90-DOTA-铃蟾肽 |
117 |
h |
2024-12-19 |
| 74810 |
cas:85916-13-8，NH-bis(C1-Boc)，亚氨基二乙酸二异丁酯 |
117 |
zyl |
2024-12-19 |
| 74811 |
Anti-CD19 (clone huB4)-Mc-MMAF-ADC分子 |
70 |
zyl |
2024-12-19 |
| 74812 |
Boc-Val-Cit-PAB-PNP cas:870487-10-8 |
67 |
zyl |
2024-12-19 |
| 74813 |
cas:2353409-70-6 MMAF-methyl ester |
131 |
zyl |
2024-12-19 |
| 74814 |
DOTA-ipilimumab 螯合剂DOTA缀合单克隆抗体ipilimumab |
81 |
h |
2024-12-19 |
| 74815 |
双功能单膦酸Ln-DOTA衍生物 |
108 |
h |
2024-12-19 |
| 74816 |
Cu-DOTA-阿伦膦酸盐 Cu-DOTA-alendronate |
102 |
h |
2024-12-19 |
| 74817 |
Mc-3377的介绍 |
83 |
zyl |
2024-12-19 |
| 74818 |
Endo-BCN-PEG4-Val-Cit-PAB-MMAF的介绍 |
83 |
zyl |
2024-12-19 |
| 74819 |
(DOTA)n-PAMAM-[尼妥珠单抗-F(ab’)2]的缀合物 |
86 |
h |
2024-12-19 |
| 74820 |
cas:2055041-39-7 Mal-PEG4-Val-Cit-PAB-OH |
118 |
zyl |
2024-12-19 |
| 74821 |
DBCO-PEG3-Val-Cit-PAB-PNP的介绍 |
132 |
zyl |
2024-12-19 |
| 74822 |
(DOTA)5-十氢赖氨酸(DOTA)5-decalysine |
119 |
h |
2024-12-19 |
| 74823 |
DOTA-HPMA缀合物 DOTA共轭N-(2-羟丙基)甲基丙烯酰胺聚合物 |
95 |
h |
2024-12-19 |
| 74824 |
G3-cNGR肽缀合物 |
121 |
h |
2024-12-19 |
| 74825 |
DOTA-USMSN DOTA偶联介孔二氧化硅纳米颗粒 |
81 |
h |
2024-12-19 |
| 74826 |
Gd-DOTA-CC9 环肽CC9偶联Gd-DOTA |
132 |
h |
2024-12-19 |
| 74827 |
DOTA-尼妥珠单抗缀合物 DOTA-NIM |
68 |
h |
2024-12-19 |
| 74828 |
DOTA功能化杯[4]芳烃 DOTA-Calix[4]arenes |
82 |
h |
2024-12-19 |
| 74829 |
DOTA-Modified 2-Hydroxypropyl-β-Cyclodextrin/4-Sulfobutyl Ether-β-Cyclodextrin-Based Polyrotaxanes |
61 |
h |
2024-12-19 |
| 74830 |
CQDs-DOTA-Eu 铕-DOTA螯合物功能化碳量子点 |
133 |
h |
2024-12-19 |
| 74831 |
DOTA-曲普瑞林 DOTA-TRP |
79 |
h |
2024-12-19 |
| 74832 |
DOTA-Boron-ENPY 大环DOTA偶联16氨基酸的NPY衍生物 |
104 |
h |
2024-12-19 |
| 74833 |
DOTA-CDP1 DOTA功能化凯萨林菌素衍生肽 |
101 |
h |
2024-12-19 |
| 74834 |
Fe3O4@SiO2-APTES-DOTA-Teniposide 氧化铁@二氧化硅核壳纳米粒子偶联DOTA分子共轭替尼泊苷药物 |
134 |
h |
2024-12-19 |
| 74835 |
DOTA-吉西他滨 DOTA-gem |
151 |
h |
2024-12-19 |
齐岳微信公众号
官方微信
库存查询